Jump to content

PubMed RSS Feed - -Subtype-Specific Off-Label Treatment of Rosacea


Recommended Posts

Case Rep Dermatol. 2021 Feb 16;13(1):121-128. doi: 10.1159/000511984. eCollection 2021 Jan-Apr.


We present 2 cases of rosacea that were successfully managed with off-label treatment. The first is a case of painful, exuding papulopustular lesions of the nose treated with rifaximin, and the other is a case of severe, debilitating and painful flushing treated with sumatriptan. The cases support previous notions that gastrointestinal comorbidities may be related to papulopustular lesions and that flushing may be related to neurogenic inflammation and migraine. The cases also imply that a new approach to rosacea management, based on endotypes and comorbidities, may be warranted.

"Interestingly, infusion of CGRP in patients with migraine induces flushing and can trigger migraine attacks. The anti-migraine drug sumatriptan has been found to block release of CGRP, which may explain the effect in the presented case."

PMID:33790755 | PMC:PMC7989675 | DOI:10.1159/000511984 

{url} = URL to article • Full Text

Sumatriptan has been added to the list of prescription treatments for flushing avoidance


Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...

Important Information

Terms of Use